CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure Contemporary use of drug-coated balloons in coronary artery disease: Where are we now? Chronic Kidney Disease and Coronary Artery Disease 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization) Two-Year Outcomes and Predictors of Target Lesion Revascularization for Non-Left Main Coronary Bifurcation Lesions Following Two-Stent Strategy With 2nd-Generation Drug-Eluting Stents Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement Contrast-Associated Acute Kidney Injury and Serious Adverse Outcomes Following Angiography 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review Intravascular ultrasound-guided drug-eluting stent implantation is associated with improved clinical outcomes in patients with unstable angina and complex coronary artery true bifurcation lesions

Original Research2020 Oct 20;33(3):108288.

JOURNAL:Cell Rep. Article Link

Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure

DM Cibi, KW Bi-Lin, MK Singh et al. Keywords: EHMT1/2; Myc; Prdm16; aging; cardiac fibrosis; cardiac hypertrophy; cardiac metabolism; heart failure; mitochondrial defects

Full Text PDF